朗欧医药LONGER品牌怎么样 申请店铺

我要投票 朗欧医药LONGER在医疗器械行业中的票数:297 更新时间:2025-06-08
朗欧医药LONGER是哪个国家的品牌?「朗欧医药LONGER」是 深圳朗欧医药集团有限公司 旗下著名品牌。该品牌发源于广东省深圳市,由创始人邹翔在2004-07-09期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力朗欧医药LONGER品牌出海!将品牌入驻外推网,定制朗欧医药LONGER品牌推广信息,可以显著提高朗欧医药LONGER产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

朗欧医药LONGER怎么样

朗欧医药集团成立于2000年6月,是一家集医药研发、生产、销售的集团公司。集团拥有江苏朗欧药业有限公司(江苏徐州)、烟台中洲制药有限公司(山东烟台)、广西玉兰制药有限公司(广西梧州)、江苏圣朗药业有限公司(江苏南京)等GMP工业以及深圳朗欧及武汉朗帛GSP商业,拥有员工1500余人。

朗欧集团拥有丰富的产品线。产品覆盖抗生素类、消化类、神经类、精神类、麻醉类、呼吸类、心血管类等治疗领域,拥有221个药品批文。其中,广西玉兰制药有限公司产品定位:清热解毒专家,拥有痔疮片、功劳去火片、利尔眠片、桑椹颗粒等品种;烟台中洲制药有限公司产品定位:妇儿健康的守护者,拥有金莲花分散片、血宁片、心安宁片、叶酸片等品种。拥有复方双花颗粒、胃肠宁片、胃肠宁颗粒、格列吡嗪胶囊、复方氨酚葡锌片等核心产品;江苏朗欧药业有限公司产品定位:精麻药经典品牌,拥有氯硝西泮注射液、艾司唑仑注射液、氟哌啶醇注射液、氯普噻吨注射液、多塞平注射液等一批精麻药品。

朗欧集团拥有强大的生产能力。公司拥有片剂、胶囊剂、颗粒剂、糖浆剂、茶剂、注射剂等多条生产线。其中,广西玉兰制药有限公司年产片剂22亿片、颗粒剂1500吨、糖浆剂60万升、茶剂1300吨;烟台中洲制药有限公司年产片剂10亿片、胶囊剂2亿粒;江苏圣朗药业有限公司年产片剂10亿片、胶囊5亿粒、颗粒5千万袋、中药提取1000吨;江苏朗欧药业有限公司(原徐州莱恩药业有限公司)年产小容量注射剂可达10亿支。

朗欧集团拥有健全的营销网络。在全国建有10大事业部(国药事业部、心血管事业部、儿药事业部、精麻药事业部、呼吸事业部、抗感染事业部、坤药事业部、药械事业部、基低药事业部、品牌事业部)、30个省总大办事处,近千名销售精英。营销触角深入地县,产品进入全国10000多家医院及第2、第3终端。

朗欧集团拥有深厚的企业文化。多年的发展朗欧孕育和沉淀了具有自身特色的企业文化,倡导“团队精神、以人为本、孝敬父母、社会责任”的核心价值观;打造“感恩文化、欣赏文化、反省文化、宝宝文化、PK文化、勤俭文化及快乐文化”的企业文化;树立“做百年朗欧,做百强朗欧”的企业愿景;坚守“助力民族制药,守护国人健康”的企业使命。

朗欧集团拥有创新的发展理念。从产品创新到学术创新,从渠道创新到模式创新,朗欧集团的发展,一直就在创新的路上......聚焦资源,合力营销,联盟商业,创造多赢,这是朗欧在新医药形势下的再次创新之举。创新的朗欧,开放的朗欧,诚信的朗欧,共享的朗欧,愿与您一道搭建工商联盟的战略合作平台,同舟共济,携手奋进。


Founded in June 2000, longou Pharmaceutical Group is a group company integrating pharmaceutical research and development, production and sales. The group has GMP industries such as Jiangsu longou Pharmaceutical Co., Ltd. (Xuzhou, Jiangsu), Yantai Zhongzhou Pharmaceutical Co., Ltd. (Yantai, Shandong), Guangxi Yulan Pharmaceutical Co., Ltd. (Wuzhou, Guangxi), Jiangsu Shenglang Pharmaceutical Co., Ltd. (Nanjing, Jiangsu), and GSP businesses of Shenzhen longou and Wuhan Longbo, with more than 1500 employees. Longou group has a rich product line. The products cover antibiotic, digestive, neurological, mental, anesthetic, respiratory, cardiovascular and other treatment fields, with 221 drug approvals. Among them, the product positioning of Guangxi Yulan Pharmaceutical Co., Ltd.: a heat clearing and detoxifying expert, with hemorrhoids tablets, Gonglaoquhuo tablets, lilmian tablets, mulberry granules and other varieties; Yantai Zhongzhou Pharmaceutical Co., Ltd. Product Positioning: the guardian of women and children's health, with Jinlianhua dispersible tablets, Xuening tablets, Xinanning tablets, folic acid tablets and other varieties. The company has core products such as compound Shuanghua granules, Weichangning tablets, Weichangning granules, glipizide capsules, compound paracetamol and zinc gluconate tablets, etc.; the product positioning of Jiangsu longou Pharmaceutical Co., Ltd.: classic brand of fine anesthetics, with a batch of fine anesthetics such as clonazepam injection, estazolam injection, haloperidol injection, chloroprothiazide injection, doxepin injection, etc. Longou group has a strong production capacity. The company has tablet, capsule, granule, syrup, tea, injection and other production lines. Among them, Guangxi Yulan Pharmaceutical Co., Ltd. has an annual output of 2.2 billion tablets, 1500 tons of granules, 600000 liters of syrup and 1300 tons of tea; Yantai Zhongzhou Pharmaceutical Co., Ltd. has an annual output of 1 billion tablets and 200 million capsules; Jiangsu Shenglang Pharmaceutical Co., Ltd. has an annual output of 1 billion tablets, 500 million capsules, 50 million bags of granules and 1000 tons of traditional Chinese medicine extraction; Jiangsu longou Pharmaceutical Co., Ltd. (formerly Xuzhou Laien) Pharmaceutical Co., Ltd.) has an annual output of 1 billion small volume injections. Longou group has a sound marketing network. There are 10 business departments (national drug business department, cardiovascular business department, pediatrics business department, fine and anesthetics business department, respiratory business department, anti infection business department, Kun drug business department, pharmaceutical machinery business department, basic and low drug business department, brand business department), 30 provincial general offices and nearly 1000 sales elites. The products have entered more than 10000 hospitals and the second and third terminals. Longou group has a profound corporate culture. With years of development, longou has nurtured and precipitated its own corporate culture with its own characteristics, advocating the core values of "team spirit, people-oriented, filial piety to parents, and social responsibility"; building a corporate culture of "gratitude culture, appreciation culture, reflection culture, baby culture, PK culture, thrifty culture and happy culture"; establishing an enterprise of "being a longou for a century, being a top 100 longou" Vision: adhere to the corporate mission of "help national pharmaceutical, protect people's health". Longou group has innovative development concept. From product innovation to academic innovation, from channel innovation to model innovation, the development of longou group has always been on the way of innovation... Focusing on resources, joint marketing, alliance business, creating multi win, this is the second innovation of longou in the new pharmaceutical situation. The innovative, open, honest and shared longou are willing to work with you to build a strategic cooperation platform for business alliance, work together in the same boat and forge ahead hand in hand.

本文链接: https://brand.waitui.com/40e73e693.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

洪灏辞任华福国际CEO

记者获悉,知名策略师洪灏日前已辞任华福国际(香港)金融控股有限公司CEO一职,目前担任其本人公司Lotus Asset Management的管理合伙人兼首席投资官。华福国际在回应记者采访时表示,公司尊重洪灏基于个人职业规划作出的决定,今后将与洪灏在相关业务领域继续保持合作。目前华福国际各项业务进展顺利,核心团队稳定,未来将持续推进国际化战略。(每经网)

29分钟前

国产具身大模型首次获得汽车制造全场景验证

6月7日,东风柳州汽车有限公司与智平方(深圳)科技有限公司在深圳正式签署战略合作协议,双方将共同探索具身大模型在汽车制造全方位场景的首次深度应用。根据协议,搭载智平方全域全身VLA(GOVLA)大模型的通用智能机器人AlphaBot 2(爱宝)将首次进驻东风柳汽汽车工厂,在上下料、拖拽料车、贴挡风玻璃标签、收纳保护布等多个场景执行智能化作业。这标志着国产具身大模型首次获得汽车制造全场景验证。(新浪财经)

29分钟前

微软将对人工智能模型的“安全性”进行排名

微软将对人工智能模型的“安全性”进行排名。(新浪财经)

29分钟前

鸿蒙电脑构建了从芯片到系统的自主体系

赛迪智库信息化与软件产业研究所信息技术研究室副主任王洁琼分析,鸿蒙PC(个人电脑)构建了从芯片到系统的自主体系,一定程度上打破了Windows、macOS等国外产品的长期商业垄断,有望实现国产操作系统在个人电脑消费市场的规模化商用。目前,鸿蒙操作系统的主要市场是在手机、平板、汽车等移动终端,推出鸿蒙PC将延续其移动端的用户优势及产品能力,对PC端大众消费市场格局有较大影响。(经济日报)

29分钟前

Meta 首席技术官:今年是增强与虚拟现实业务的“关键之年”

Meta 首席技术官 Andrew “Boz” Bosworth 近期在接受采访时表示,2025 年可能是 Meta 旗下现实实验室(Reality Labs)的“伟大之年(the year of greatness)”,也可能是元宇宙沦为“传奇失败案例”的一年。而如今,Bosworth 看起来更倾向于相信其有实现伟大的潜力,但最终的决定权仍在市场手中。(IT之家)

29分钟前

本页详细列出关于朗欧医药LONGER的品牌信息,含品牌所属公司介绍,朗欧医药LONGER所处行业的品牌地位及优势。
咨询